MAPK1 and non-small cell lung carcinoma: These data suggest thatmiR-346 may promote NSCLC cell growth, migration and invasion, and suppress NSCLC cell apoptosis through targeting 3′-UTR of XPC mRNA, leading to inhibition of XPC protein expression, and then contributing to the activation of the ERK pathway.